LifeScience

Salesforce Steps Up Competition with Veeva by Targeting Pharmaceutical Customers

3 months ago

In a bold move to strengthen its foothold in the pharmaceutical sector, Salesforce has recently intensified its efforts to attract drug manufacturers away from its primary competitor, Veeva Systems. This strategic maneuver comes in light of Salesforce's ambitious plans to expand its offerings tailored specifically for the pharmaceutical industry, capitalizing on a growing demand for innovative customer relationship management solutions.

Merck KGaA Surpasses Expectations Driven by Life Science Segment Growth

5 months ago

Merck KGaA, a globally recognized science and technology company, has reported better-than-expected financial results for the third quarter of 2024, attributing much of its success to a significant surge in its life science division. The company’s earnings indicate a robust performance that is likely to capture the attention of investors keen on biopharmaceuticals and lab technologies.